Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Merck faces a class-action lawsuit over alleged misrepresentation of its mumps vaccine potency, claiming anticompetitive ...

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...

is set to be available in veterinary clinics and hospitals across the United States this fall. NOBIVAC NXT FeLV is the first FeLV vaccine leveraging Merck's RNA-particle platform, similar to the ...

Merck & Co will help make rival Johnson & Johnson's single-shot Covid-19 vaccine in a partnership set to be announced on Tuesday by US President Joe Biden, a White House official said. J&J's ...

Merck & Co. escaped antitrust claims by a group physicians who alleged that they bought the company’s mumps vaccine at inflated prices because it deceived the government to maintain its monopoly on ...

Merck’s ongoing pneumococcal vaccine development program is designed to provide options that address the specific needs of different populations, including infants and children, healthy adults ...

There is also growing global concern about antimicrobial resistance in agriculture and veterinary ... virus. Merck Animal ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

Vaccines – If your dog is not vaccinated ... are at a lower risk for developing cancer, according to a Merck Veterinary Manual study. In female dogs, for example, the more heat cycles she experiences ...